Roger D. Tung

Insider Reports History

Entity
Individual
Location
99 Hayden Avenue, Suite 500, Lexington, MA
Signature
/s/ Jeffrey A. Munsie, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roger D. Tung:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CONCERT PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 0 $8.33 Mar 6, 2023 By RD Tung Irrevocable Trust
CONCERT PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 0 $8.33 Mar 6, 2023 By Roger D. Tung 2011 GRAT
CONCERT PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 0 $8.33 Mar 6, 2023 By Tung Family Investment Trust
CONCERT PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 0 $8.33 Mar 6, 2023 Direct
CONCERT PHARMACEUTICALS, INC. Chief Executive Officer, Director Performance Stock Units 0 Mar 6, 2023 Direct
CONCERT PHARMACEUTICALS, INC. Chief Executive Officer, Director Stock Option (Right to Buy) 0 Mar 6, 2023 Direct

Insider Reports Filed by Roger D. Tung

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNCE CONCERT PHARMACEUTICALS, INC. Mar 6, 2023 13 $0 4 Mar 6, 2023 Chief Executive Officer, Director
CNCE CONCERT PHARMACEUTICALS, INC. Jan 6, 2023 1 -$66.9K 4 Jan 9, 2023 Chief Executive Officer, Director
CNCE CONCERT PHARMACEUTICALS, INC. Feb 15, 2022 1 -$41.7K 4 Feb 16, 2022 Chief Executive Officer, Director
CNCE CONCERT PHARMACEUTICALS, INC. Jan 28, 2022 2 $0 4 Feb 1, 2022 Chief Executive Officer, Director
CNCE CONCERT PHARMACEUTICALS, INC. Jan 6, 2022 3 -$28.6K 4 Jan 7, 2022 Chief Executive Officer, Director
CNCE CONCERT PHARMACEUTICALS, INC. Dec 13, 2021 3 -$804 4 Dec 15, 2021 Chief Executive Officer, Director